Philip Goulder

University of Oxford - Department of Paediatrics

United Kingdom

SCHOLARLY PAPERS

3

DOWNLOADS
Rank 19,083

SSRN RANKINGS

Top 19,083

in Total Papers Downloads

3,140

SSRN CITATIONS

4

CROSSREF CITATIONS

0

Scholarly Papers (3)

T-Cell and Antibody Responses to First BNT162b2 Vaccine Dose in Previously SARS-CoV-2-Infected and Infection-Naive UK Healthcare Workers: A Multicentre, Prospective, Observational Cohort Study

Number of pages: 55 Posted: 25 Mar 2021
University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Liverpool - HPRU in Emerging and Zoonotic Infections, Newcastle University - Translational and Clinical Research Institute, University of Oxford - Sir William Dunn School of Pathology, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Liverpool - HPRU in Emerging and Zoonotic Infections, Sheffield Teaching Hospitals NHS Foundation Trust, University of Liverpool - HPRU in Emerging and Zoonotic Infections, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Oxford - Nuffield Department of Clinical Neurosciences, Public Health England Colindale, University of Liverpool - HPRU in Emerging and Zoonotic Infections, University of Liverpool - Institute of Infection, Veterinary and Ecological Sciences, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, Newcastle University - Translational and Clinical Research Institute, Newcastle University - Translational and Clinical Research Institute, Newcastle University - Translational and Clinical Research Institute, University of Oxford - Peter Medawar Building for Pathogen Research, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, Sheffield Teaching Hospitals NHS Foundation Trust, Government of the United Kingdom - Oxford University Hospitals NHS Foundation Trust, Government of the United Kingdom - Oxford University Hospitals NHS Foundation Trust, University of Oxford - Department of Paediatrics, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Oxford Vaccine Group, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, Public Health England Colindale, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance, Public Health England Colindale, University of Oxford - Sir William Dunn School of Pathology, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Birmingham - Clinical Immunology Service, Newcastle upon Tyne Hospitals NHS Foundation Trust - Department of Infection and Tropical Medicine, Oxford University Hospitals NHS Foundation Trust, University of Oxford - Wellcome Centre for Human Genetics, University of Liverpool - Institute of Infection, Veterinary and Ecological Sciences, Sheffield Teaching Hospitals NHS Foundation Trust - South Yorkshire Regional Department of Infection and Tropical Medicine and affiliation not provided to SSRN
Downloads 2,597 (5,922)
Citation 1

Abstract:

Loading...

T-Cell and Antibody Responses to First BNT162b2 Vaccine Dose in Previously SARS-CoV-2-Infected and Infection-Naive UK Healthcare Workers: A Multicentre, Prospective, Observational Cohort Study

Number of pages: 55 Posted: 13 Apr 2021
University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Liverpool - HPRU in Emerging and Zoonotic Infections, Newcastle University - Translational and Clinical Research Institute, University of Oxford - Sir William Dunn School of Pathology, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - Peter Medawar Building for Pathogen Research, University of Liverpool - HPRU in Emerging and Zoonotic Infections, Sheffield Teaching Hospitals NHS Foundation Trust, University of Oxford - Nuffield Department of Clinical Neurosciences, Public Health England Colindale, University of Liverpool - HPRU in Emerging and Zoonotic Infections, University of Liverpool - Institute of Infection, Veterinary and Ecological Sciences, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, Newcastle University - Translational and Clinical Research Institute, Newcastle University - Translational and Clinical Research Institute, Newcastle University - Translational and Clinical Research Institute, University of Oxford - Peter Medawar Building for Pathogen Research, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, Sheffield Teaching Hospitals NHS Foundation Trust, Government of the United Kingdom - Oxford University Hospitals NHS Foundation Trust, Government of the United Kingdom - Oxford University Hospitals NHS Foundation Trust, University of Oxford - Department of Paediatrics, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Oxford Vaccine Group, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, Public Health England Colindale, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance, Public Health England Colindale, University of Oxford - Sir William Dunn School of Pathology, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Birmingham - Clinical Immunology Service, Newcastle upon Tyne Hospitals NHS Foundation Trust - Department of Infection and Tropical Medicine, Oxford University Hospitals NHS Foundation Trust, University of Oxford - Wellcome Centre for Human Genetics, University of Liverpool - Institute of Infection, Veterinary and Ecological Sciences, Sheffield Teaching Hospitals NHS Foundation Trust - South Yorkshire Regional Department of Infection and Tropical Medicine and affiliation not provided to SSRN
Downloads 299 (122,244)

Abstract:

Loading...

2.

Safety and Immunogenicity of the ChAdox1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 in HIV Infection

Number of pages: 39 Posted: 19 Apr 2021
University of Oxford, University of Oxford - Jenner Institute, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, Imperial College London - Department of Infectious Disease, University of Oxford - Oxford Vaccine Group, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, NIHR Imperial Clinical Research Facility, University of Oxford - The Jenner Institute, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - The Jenner Institute, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, University of Oxford - Wellcome Centre for Human Genetics, University of Oxford - Oxford Vaccine Group, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, University of Oxford - Jenner Institute, University of Oxford - The Jenner Institute, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, University College London - Department of Infection, University of Oxford - Jenner Institute, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - The Jenner Institute, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, University of Oxford - Peter Medawar Building for Pathogen Research, Imperial College London - Department of Infectious Disease, University of Oxford - Oxford Vaccine Group, NIHR Imperial Clinical Research Facility, University of Oxford - Oxford Vaccine Group, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, University of Oxford - Oxford Vaccine Group, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, NIHR Guy's and St Thomas' Biomedical Research Centre, Imperial College London - Department of Infectious Disease, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Oxford Vaccine Group, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, University of Oxford - Peter Medawar Building for Pathogen Research, Oxford University Hospitals NHS Foundation Trust, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Department of Paediatrics, University of Oxford - Peter Medawar Building for Pathogen Research, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, Imperial College London - Department of Infectious Disease, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - The Jenner Institute, University of Oxford - Oxford Vaccine Group, Imperial College London - Department of Medicine, Guy's and St Thomas' NHS Foundation Trust - Harrison Wing, University of Oxford - Jenner Institute and affiliation not provided to SSRN
Downloads 237 (157,029)

Abstract:

Loading...

3.

Lymph Node Innate Lymphoid Cells (ILCs) in HIV Infected Children are Highly Activated Despite Sustained Depletion in Blood

Number of pages: 46 Posted: 20 Aug 2019
Africa Health Research Institute, Africa Health Research Institute, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, University of Oxford - Department of Paediatrics, Africa Health Research Institute, Africa Health Research Institute, Africa Health Research Institute, Africa Health Research Institute, Africa Health Research Institute, University of Oxford - Department of Paediatrics, University of KwaZulu-Natal - ENT Department, Africa Health Research Institute, University of KwaZulu-Natal - HIV Pathogenesis Programme, Massachusetts Institute of Technology (MIT) - David H. Koch Institute for Integrative Cancer Research, University of Oxford - Department of Paediatrics, Africa Health Research Institute and Africa Health Research Institute
Downloads 7 (708,875)

Abstract:

Loading...

Innate Lymphoid Cells (ILCs), Paediatric HIV infection, Paediatric Slow Progression, ILCs in paediatric HIV infected lymphoid tissue, Transcriptional profiling of lymphoid tissue ILCs (RNAseq)